| Автор | Mascia, A |
| Автор | Qqaacute;fra, J |
| Автор | Schoenen, J |
| Дата выпуска | 1998 |
| dc.description | The dopamine theory of migraine pathogenesis, first proposed by F. Sicuteri in 1977, has attracted renewed interest after an increased frequency of the dopamine D2 receptor (DRD2) gene allele NcoI C was found in patients with migraine with aura. Therefore we reviewed the relevant literature. The most compelling argument favoring an interictal hypersensitivity of dopamine receptors in migraineurs stems from pharmacologic studies of the gastric and autonomic effects of dopaminergic agents such as apomorphine, but none of these studies was blinded and placebo-controlled. Various DRD2 antagonists abort migraine attacks after parenteral administration, while mere is circumstantial evidence that dopamine agonists may be useful for prophylaxis. Most drugs used in these trials, however, lack selectivity for dopamine receptors. Both in pharmacological and therapeutic studies most patients had migraine without aura. We conclude that data suggesting a primary role for the dopaminergic system in migraine pathogenesis are unconvincing. Based on well established interactions between central amines, a reduced release of serotonin between attacks could lower dopamine release which would lead to receptor hypersensitivity. |
| Издатель | SAGE Publications |
| Тема | Dopamine |
| Тема | migraine |
| Тема | pathogenesis |
| Тема | receptors |
| Название | Dopamine and Migraine: A Review of Pharmacological, Biochemical, Neurophysiological, and Therapeutic Data |
| Тип | Reviews |
| DOI | 10.1046/j.1468-2982.1998.1804174.x |
| Electronic ISSN | 1468-2982 |
| Print ISSN | 0333-1024 |
| Журнал | Cephalalgia |
| Том | 18 |
| Первая страница | 174 |
| Последняя страница | 182 |
| Аффилиация | Mascia, A, Department of Neurology, CHR Citadelle, University of Liège, Liège, Belgium |
| Аффилиация | Qqaacute;fra, J, Department of Neurology, CHR Citadelle, University of Liège, Liège, Belgium |
| Аффилиация | Schoenen, J, Department of Neurology, CHR Citadelle, University of Liège, Liège, Belgium |
| Выпуск | 4 |
| Библиографическая ссылка | Humphrey, PP, W Feniuk, AS Marriott, RJ Tanner, MR Jackson and ML Tucker. Preclinical studies on the anti-migraine drug, sumatriptan. Eur Neurol 1991;31:282–90 |
| Библиографическая ссылка | Ferrari, MD and PR Saxena. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993;13:151–65 |
| Библиографическая ссылка | Wang, W, M Timsit-Berthier and J Schoenen. Intensity dependence of auditory evoked potentials in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996;46:1404–9 |
| Библиографическая ссылка | Sicuteri, F. Dopamine, the second putative protagonist in headache. Headache1977;17:129–31 |
| Библиографическая ссылка | Peroutka, SJ, T Wilhoit and K Jones. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 1997;49:201–6 |
| Библиографическая ссылка | Del Zompo, M, A Cherchi, M Ponti, M Lai and MP Piccardi. Association study between dopamine D2, D3 and D4 receptor genes and migraine without aura in a Sardinian sample. Cephalalgia 1997;17:329 |
| Библиографическая ссылка | Hyde, TM, MB Knable and AM Murray. Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex. Synapse 1996;24:224–32 |
| Библиографическая ссылка | Kohli, JD, D Glock and LI Goldberg. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery. Eur J Pharmacol 1983;89:137–41 |
| Библиографическая ссылка | Sicuteri, F, M Bonucci, F Cangi, U Pietrini and M Fanciullacci. Syncope and dopamine-receptor hyperreactivity: myths and facts about basilar artery migraine. In: JD Carroll, V Pfaffenrath and O Sjaastad, editors. Migraine and beta-blockade. Molndal: Hassle AB, 1985: 147–60 |
| Библиографическая ссылка | Chudler, EH and WK Dong. The role of the basal ganglia in nociception and pain. Pain 1995;60:3–38 |
| Библиографическая ссылка | Paalzow, GHM. L-Dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses. J Pharmacol Exp Ther1992;263:470–9 |
| Библиографическая ссылка | Miley, DP, AA Abrams, JH Atkinson and DS Janowsky. Successful treatment of thalamic pain with apomorphine. Am J Psychiatry 1978;135:1230 |
| Библиографическая ссылка | Grant, R and PO Behan. Resistant thalamic pain treated by levodopa. Br Med J 1984;289:1272 |
| Библиографическая ссылка | Kernbaum, S and J Hauchecorne. Administration of levodopa for relief of herpes zoster pain. J Am Med Assoc 1981;246:132–4 |
| Библиографическая ссылка | Nutt, JG and JH Carter. Sensory symptoms in Parkinsonism related to central dopaminergic function. Lancet 1984;ii:456–7 |
| Библиографическая ссылка | Quinn, NP, AE Lang, WC Koller and CD Marsden. Painful Parkinson disease. Lancet 1986;i:1366–9 |
| Библиографическая ссылка | Lorentz, IT. A survey of headache in Parkinson's disease. Cephalalgia1989;9:83–6 |
| Библиографическая ссылка | Van Hilten, JJ. The migraine-dopamine link: do migraine and Parkinson's disease coexist? Clin Neurol Neurosurg 1992; Suppl 94:168–70 |
| Библиографическая ссылка | Sabatini, U, O Rascol, A Rascol and J Montastruc. Migraine attacks induced by subcutaneous apomorphine in two migrainous Parkinsonian patients. Clin Neuropharmacol 1990;13:264–7 |
| Библиографическая ссылка | Guan, XM and WJ McBride. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 1989;23:541–7 |
| Библиографическая ссылка | Boulenguez, P, JN Rawlins, J Chauveau, MH Joseph, SN Mitchell and JA Gray. Modulation of dopamine release in the nucleus accumbens by 5HT1B agonists: involvement of the hippocampo-accumbens pathway. Neuropharmacology 1996;35:1521–5 |
| Библиографическая ссылка | Iyer, RN and CW Bradberry. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J Pharmacol Exp Ther 1996;277:40–7 |
| Библиографическая ссылка | Nissbrandt, H, N Waters and S Hjorfh. The influence of serot-oninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn Schmiedebergs Arch Pharmacol 1992;346:12–9 |
| Библиографическая ссылка | Benloucif, S, MJ Keegan and MP Galloway. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 1993;265:373–7 |
| Библиографическая ссылка | Saito, H, M Matsumoto, H Togashi and M Yoshioka. Functional interaction between serotonin and other neuronal systems: focus on in vivo microdialysis studies. Jpn J Pharmacol 1996;70:203–5 |
| Библиографическая ссылка | Blin, O, JP Azulay, G Masson, G Aubrespy and G Serratrice. Apomorphine-induced yawning in migraine patients: enhanced responsiveness. Clin Neuropharmacol 1991;14:91–5 |
| Библиографическая ссылка | Del Bene, E, M Poggioni and F De Tommasi. Video assessment of yawning induced by sublingual apomorphine in migraine. Headache 1994;34:536–8 |
| Библиографическая ссылка | Del Zompo, M, M Lai, V Loi and MR Pisano. Dopamine hypersensitivity in migraine: role in apomorphine syncope. Headache 1995;35:222–4 |
| Библиографическая ссылка | Cerbo, R, P Barbanti, MG Buzzi, G Fabbrini, L Brusa and C Roberti et al. Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol 1997;20:36–41 |
| Библиографическая ссылка | Fanciullacci, M, S Michelacci, C Curradi and F Sicuteri. Hyperre-sponsiveness of migraine patients to the hypotensive action of bromocriptine. Headache 1980;20:99–102 |
| Библиографическая ссылка | Serra, G, M Collu and GL Gessa. Yawning is elicited by D2 dopamine agonists but is blocked by D1 antagonists, SCH 23390. Psychopharmacology 1987;91:330–3 |
| Библиографическая ссылка | Bès, A, B Comet, P Dupui, A Guell, MC Arne-Bès and G Géraud. Antimigraine drugs and dopamine hypersensitivity. In: WK Amery, JM Van Nueten and A Wauquier, editors. The pharmacological basis of migraine therapy. London: Pitman Press, 1984 202–12 |
| Библиографическая ссылка | Calabresi, P, M Silvestrini, F Stratta, LM Cupini, G Arigo and GP Atzei et al. 1-Deprenyl test in migraine: neuroendocrinological aspects. Cephalalgia 1993;13:406–9 |
| Библиографическая ссылка | International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1–96 |
| Библиографическая ссылка | Pradalier, A, JM Launay, J Dry, C Dreux and C Artigou. Migraine commune. Variations des catécholamines conjuguées et non conjuguées. Presse Med 1985;14:583–5 |
| Библиографическая ссылка | D'Andrea, G, KMA Welch, S Nagel-Leiby, S Grunfeld and R Joseph. Platelet catecholamines in migraine. Cephalalgia 1989;9:3–5 |
| Библиографическая ссылка | Nagel-Leiby, S, KMA Welch, G D'Andrea, S Grunfeld and E Brown. Event-related slow potentials and associated catecholamine function in migraine. Cephalalgia 1990;10:317–29 |
| Библиографическая ссылка | Kovács, K, L Bors, L Tóthfalusi, I Jelencsik, Gy Bozsik and L Kerényi et al. . Cerebrospinal fluid (CSF) investigations in migraine. Cephalalgia 1989;9:53–7 |
| Библиографическая ссылка | Castillo, J, F Martinez, C Suarez, J Naveiro, M Lema and M Noya. Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenyiacetic acid levels in migraine patients. Cephalalgia 1996;16:56–61 |
| Библиографическая ссылка | Barbanti, P, E Bronzetti, A Ricci, R Cerbo, G Fabbrini and MG Buzzi et al. Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci Lett 1996;207:73–6 |
| Библиографическая ссылка | Timsit-Berthier, M, H Mantanus, P Marissiaux, M Ansseau, A Doumont and V Geenen et al. CNV and dopamine receptor reactivity: correlations with the apomorphine test. Electroen-cephalogr Clin Neurophysiol Suppl 1986;38:403–5 |
| Библиографическая ссылка | Schoenen, J, A Maertens de Noordhout, M Timsit-Berthier and M Timsit. Contingent negative variation (CNV) as a diagnostic and Physiopathologic tool in headache patients. In: Clifford Rose, editor. Migraine. Proc 5th Int Migraine Symp, London 1984. Basel: Karger, 1985: 17–25 |
| Библиографическая ссылка | Lenarduzzi, P, M Timsit-Berthier, P Gérard and J Schoenen Variation contingent negative (VCN) dans la migraine avec aura ("migraine classique") en période intercritique. Société Française d'études des migraines et céphalées. Association pour la Neuro-psyco-pharmacologie 1988: 17–8 |
| Библиографическая ссылка | Böcker, KBE, M Timsit-Berthier, J Schoenen and CHM Brunia. Contingent negative variation in migraine. Headache 1990;30:604–9 |
| Библиографическая ссылка | Kropp, P and WD Gerber. Contingent negative variation—findings and perspectives in migraine. Cephalalgia 1993;13:33–6 |
| Библиографическая ссылка | Kropp, P and WD Gerber. The predictable migraine attack. News in Headache 1994;4:3 |
| Библиографическая ссылка | Kropp, P and WD Gerber. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia 1995;15:123–8 |
| Библиографическая ссылка | Kropp, P, WD Gerber and V Repas. Can migraine attacks be predicted by evaluation of contingent negative variation? Cephalalgia 1997;17:266 |
| Библиографическая ссылка | Schoenen, J, W Wang, A Albert and PJ Delwaide. Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. Eur J Neurol 1995;2:115–22 |
| Библиографическая ссылка | Áfra, J, A Proietti Cecchini, V De Pasqua, A Albert and J Schoenen. Visual evoked potentials during long-lasting pattern-reversal stimulations in migraine. Brain 1997 (in press) |
| Библиографическая ссылка | Wang, W, J Schoenen and M Timsit-Berthier. Cognitive functions in migraine without aura between attacks: a psychophysiological approach using the “oddball” paradigm. Neurophysiologie Clinique 1995;25:3–11 |
| Библиографическая ссылка | Evers, S, B Bauer, B Suhr, IW Husstedt and KH Grotemeyer. Cognitive processing in primary headache: a study on event-related potentials. Neurology 1997;48:108–13 |
| Библиографическая ссылка | Onofrj, M and I Bodis-Wollner. Dopaminergic deficiency causes delayed visual evoked potentials in rats. Ann Neurol 1982;11:484–90 |
| Библиографическая ссылка | Yamamoto, K, K Hagino, T Moroji and T Ishii. Habituation failure of skin conductance response after intraventricular administration of 6-hydroxydopamine in cats. Expérimenta 1984;40:344–5 |
| Библиографическая ссылка | Imperato, A, S Cabib and S Puglisi-Allegra. Repeated stressful experiences differently affect the time-dependent responses of the mesolimbic dopamine system to the stressor. Brain Res 1993;601:333–6 |
| Библиографическая ссылка | Volans, GN. The effect of the metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol1975;2:57–63 |
| Библиографическая ссылка | Ross-Lee, LM, MJ Eadie, V Heazlewood, F Bochner and JH Tyrer. Aspirin pharmacokinetics in migraine. The effect of metoclopramide. Eur J Clin Pharmacol 1983;24:277–35 |
| Библиографическая ссылка | Tokola, RA. The effect of metoclopramide and prochlorperazine on the absorption of effervescent paracetamol in migraine. Cephalalgia1988;8:139–47 |
| Библиографическая ссылка | Tokola, RA, P Kangasniemi, PJ Neuvonen and O Tokola. Tolfenamic acid, metoclopramide, caffeine and their combination in the treatment of migraine attacks. Cephalalgia 1984;4:253–63 |
| Библиографическая ссылка | McGregor, A, M Wilkinson and K Bancroft. Domperidone plus paracetamol in the treatment of migraine. Cephalalgia 1993;13:124–7 |
| Библиографическая ссылка | Tfelt-Hansen, P and J Olesen. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 1984;4:107–11 |
| Библиографическая ссылка | Tek, DS, DS McClellan, JS Olshaker, CL Allen and DC Arthur. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the Emergency Department. Ann Emerg Med 1990;19:1083–7 |
| Библиографическая ссылка | Hughes, JB. Metoclopramide in migraine treatment [Letter]. Med J Aust1977;2:580 |
| Библиографическая ссылка | Ellis, GL, J Delaney, DA DeHart and A Owens. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med 1993;22:191–5 |
| Библиографическая ссылка | Cameron, JD, PL Lane and M Speechley. Intravenous chlorpromazine vs metoclopramide in acute migraine headache. Acad Emerg Med 1995;2:597–602 |
| Библиографическая ссылка | Coppola, M, DM Yealy and RA Leibold. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 1995;26:541–6 |
| Библиографическая ссылка | Hakkarainen, H and H Allonen. Ergotamine vs metoclopramide vs their combination in acute migraine attacks. Headache 1982;22:10–12 |
| Библиографическая ссылка | Amery, WY and J Waelkens. Prevention of the last chance: an alternative pharmacological treatment of migraine. Headache 1983;23:37–8 |
| Библиографическая ссылка | McEwen, JI, HM O'Connor and HB Dinsdale. Treatment of migraine with intramuscular chlorpromazine. Ann Emerg Med 1987;16:758–63 |
| Библиографическая ссылка | Iserson, KV. Parenteral chlorpromazine treatment of migraine. Ann Emerg Med1983;12:756–8 |
| Библиографическая ссылка | Lane, RL and R Ross. Intravenous chlorpromazine—preliminary results in acute migraine. Headache 1985;25:302–4 |
| Библиографическая ссылка | Bell, R, D Motoya, A Shuaib and MA Lee. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990;19:1079–82 |
| Библиографическая ссылка | Jones, J, D Sklar, J Dougherty and W White. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA 1989;261:1174–6 |
| Библиографическая ссылка | Fisher, H. A new approach to emergency department therapy of migraine headache with intravenous haloperidol: a case series. J Emerg Med1995;13:119–22 |
| Библиографическая ссылка | Lugaresi, A, P Montagna, R Gallasi and E Lugaresi. Extrapyramidal syndrome and depression induced by flunarizine. Eur Neurol 1988;28:208–11 |
| Библиографическая ссылка | Piccini, P, A Nuti, AM Paoletti, A Napolitano, GB Melis and U Bonuccelli. Possible involvement of dopaminergic mechanisms in the antimigraine action of flunarizine. Cephalalgia 1990;10:3–8 |
| Библиографическая ссылка | Wöber, C, T Brücke, C Wöber-Bingöl, S Asenbaum, P Wessely and I Podreka. Dopamine D2-receptor blockade and antimigraine action of flunarizine. Cephalalgia 1994;14:135–40 |
| Библиографическая ссылка | Louis, P. A double-blind placebo controlled prophylactic study of flunarizine (Sibelium®) in migraine. Headache1981;21:235–9 |
| Библиографическая ссылка | Cerbo, R, M Casacchia, R Formisano, M Feliciani, G Cusimano and MG Buzzi et al. Flunarizine-pizotifen single dose, double-blind cross-over trial in migraine prophylaxis. Cephalalgia 1986;6:15–8 |
| Библиографическая ссылка | Lucking, HC, W Oestreich, R Schmidt and D Soyka. Flunarizine vs propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients. Cephalalgia 1988; Suppl 8:21–6 |
| Библиографическая ссылка | Soyka, D, Z Taneri, W Oestreich and R Schmidt. Flunarizine i.v. in the acute treatment of common or classical migraine attacks a placebo-controlled double blind trial. Headache 1989;29:21–7 |
| Библиографическая ссылка | Pfaffenrath, V, W Oestreich and W Haase. Flunarizine (10 and 20 mg) i.v. versus placebo in the treatment of acute migraine attacks: a multi-centre double-blind study. Cephalalgia 1990;10:77–81 |
| Библиографическая ссылка | Tfelt-Hansen, P, P Henry, LJ Mulder, RG Scheldewaert, J Schoenen and G Chazot. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995;346:923–6 |
| Библиографическая ссылка | Andersch, B, L Hahn, C Wendestam, R Ohman and L Abrahamsson. Treatment of premenstrual syndrome with bromocriptine. Acta Endocrinol 1978;88 Suppl 216:165–74 |
| Библиографическая ссылка | Andersen, AN, JF Larsen, OR Steenstrup, B Svendstrup and J Nielsen. Effect of bromocriptine on the premenstrual syndrome: a double-blind clinical trial. Br J Obstet Gynaecol 1977;84:370–4 |
| Библиографическая ссылка | Herzog, AG. Continuous bromocriptine therapy in menstrual migraine. Neurology1997;48:101–2 |
| Библиографическая ссылка | Herrmann, WM, R Horowsky, K Dannehl, U Kramer and K Lurati. Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide. Headache 1977;17:54–60 |
| Библиографическая ссылка | Sommerville, BW and WM Herrmann. Migraine prophylaxis with lisuride hydrogen maleate double-blind study of lisuride versus placebo. Headache 1978;18:75–9 |
| Библиографическая ссылка | Sances, G, M Martignoni, G Rosettino, L Fioroni, S Montorsi and I Runge et al. Lisuride in menstrual migraine prophylaxis. Cephalalgia 1989;9 Suppl 10:444–5 |
| Библиографическая ссылка | Nattero, G, L Biale and L Savi. Lisuride and pizotifen in the treatment of migraine without aura. Cephalalgia 1991; Suppl 11:217–9 |
| Библиографическая ссылка | Canonico, PL, U Scapagnini, E Genazzani and A Zanotti. Dihy-droergokryptine (DEK) in the prophylaxis of common migraine: double-blind clinical study vs placebo. Cephalalgia 1989;9 Suppl 10:445–7 |
| Библиографическая ссылка | Avella, F, A Poli, L Ambrosoli and R Girardello. The effectiveness of α-dihydroergocryptine in migraine prophylaxis: a double-blind clinical study vs placebo. Cephalalgia 1997;17:435 |
| Библиографическая ссылка | Frediani, F, L Grazzi, A Zanotti, F Mailland, BM Zappacosta and G Bussone. Dihydroergokryptine versus dihydroergotamine in migraine prophylaxis: a double-blind clinical trial. Cephalalgia 1991;11:117–21 |
| Библиографическая ссылка | Peroutka, SJ. Dopamine and migraine. Neurology1997;49:650–6 |
| Библиографическая ссылка | Waelkens, J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia1984;4:85–90 |
| Библиографическая ссылка | Agren, H, IN Mefford, MV Rudorfer, M Linnoila and WZ Potter. Interaction of neurotransmitter system. A non-experimental approach to 5-HIAA-HVA correlation in human CSF. J Psychiatr Res 1986;20:175–93 |
| Библиографическая ссылка | Ophoff, RA, GM Terwindt, MN Vergouwe, R van Eijk, PJ Oefner and SMG Hoffman et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543–52 |
| Библиографическая ссылка | Terwindt, GM, RA Ophoff, LA Sandkuijl, R van Eijk, J Haan and RR Frants et al. Involvement of the familial hemiplegic migraine gene on 19p13 in migraine with and without aura. Cephalalgia 1997;17:232 |
| Библиографическая ссылка | Codignola, A, P Tarroni, F Clementi, A Polio, M Lovallo and E Carbone et al. Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. J Biol Chem 1993;268:26240–7 |
| Библиографическая ссылка | Coming, DE, BG Coming, D Muhleman, G Dietz, B Shahbahrami and D Tast et al. The Dopamine D2 receptor locus as a modifying gene in neuropsychiatrie disorders. JAMA 1991;266:1793–800 |
| Библиографическая ссылка | Noble, EP. The gene that rewards alcoholism. Sci Med1996;3:52–61 |
| Библиографическая ссылка | Blum, K, EP Noble, PJ Sheridan, A Montgomery, T Ritche and P Jagadeeswaran et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990;263:2055–60 |
| Библиографическая ссылка | Bolos, AM, M Dean, S Lucas-Derse, M Ramsburg, GL Brown and D Goldman. Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA 1990;264:3156–60 |
| Библиографическая ссылка | Gejman, PV, A Ram and J Gelernter. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. JAMA 1994;271:204–8 |
| Библиографическая ссылка | Chabriat, H, JE Joire, J Danchot, P Grippon and MG Bousser. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicenter double-blind placebo-controlled study. Cephalalgia 1994;14:297–300 |
